Paul Bessette

Acting as principal investigator or co-investigator since 1996 in various phase II and III studies in the areas of gynecology-oncology, prevention studies on ovarian and breast cancer, genetics, hormone replacement therapy, contraception, anti-emetic therapies, and other studies on women’s health. These studies were either sponsored by pharmaceutical companies or funded by organisms such as the NCIC CTG.